C1q nephropathy in India: A single-center study

C1q nephropathy (C1qN) is defined by conspicuous C1q deposits in the glomerular mesangial regions of patients who do not have any evidence of systemic lupus erythematosus (SLE). We present our experience with C1qN over the last three years. In total, 1775 native renal biopsies were reviewed and domi...

Full description

Bibliographic Details
Main Authors: K V Kanodia, A V Vanikar, R D Patel, K S Suthar, H V Patel, M A Gumber, P R Shah, H L Trivedi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2015;volume=26;issue=2;spage=398;epage=403;aulast=Kanodia
_version_ 1818290204053602304
author K V Kanodia
A V Vanikar
R D Patel
K S Suthar
H V Patel
M A Gumber
P R Shah
H L Trivedi
author_facet K V Kanodia
A V Vanikar
R D Patel
K S Suthar
H V Patel
M A Gumber
P R Shah
H L Trivedi
author_sort K V Kanodia
collection DOAJ
description C1q nephropathy (C1qN) is defined by conspicuous C1q deposits in the glomerular mesangial regions of patients who do not have any evidence of systemic lupus erythematosus (SLE). We present our experience with C1qN over the last three years. In total, 1775 native renal biopsies were reviewed and dominant/co-dominant C1q mesangial deposits in patients with absence of clinical and/or serological evidence of SLE were considered as C1qN. Their clinical profile and renal function status were studied and correlated. C1qN was observed in 11 patients (0.61%), and included eight males and three females; the mean age was 36.6 years. The most common presentation was nephrotic syndrome. Hematuria was noted in eight patients (72%). The mean serum creatinine was 2.78 mg/dL. Hypertension was seen in two patients (18%). Mesangial proliferative glomerulonephritis (MePGN) was the most common histological pattern, followed by focal and segmental glomerulosclerosis and other lesions. The common codeposits along with C1q were IgM, followed by C3 and others. MePGN had better prognosis than others. To conclude, C1qN was noted in 0.61% of all renal biopsies with bimodal age distribution and may present as podocytopathy or non-podocytopathy. The prognosis depends on the morphological pattern and C1q deposits per se are not prognostic indicators.
first_indexed 2024-12-13T02:24:27Z
format Article
id doaj.art-be9a5331d6314b6986ef75d984c17b0f
institution Directory Open Access Journal
issn 1319-2442
language English
last_indexed 2024-12-13T02:24:27Z
publishDate 2015-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Saudi Journal of Kidney Diseases and Transplantation
spelling doaj.art-be9a5331d6314b6986ef75d984c17b0f2022-12-22T00:02:40ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422015-01-0126239840310.4103/1319-2442.152562C1q nephropathy in India: A single-center studyK V KanodiaA V VanikarR D PatelK S SutharH V PatelM A GumberP R ShahH L TrivediC1q nephropathy (C1qN) is defined by conspicuous C1q deposits in the glomerular mesangial regions of patients who do not have any evidence of systemic lupus erythematosus (SLE). We present our experience with C1qN over the last three years. In total, 1775 native renal biopsies were reviewed and dominant/co-dominant C1q mesangial deposits in patients with absence of clinical and/or serological evidence of SLE were considered as C1qN. Their clinical profile and renal function status were studied and correlated. C1qN was observed in 11 patients (0.61%), and included eight males and three females; the mean age was 36.6 years. The most common presentation was nephrotic syndrome. Hematuria was noted in eight patients (72%). The mean serum creatinine was 2.78 mg/dL. Hypertension was seen in two patients (18%). Mesangial proliferative glomerulonephritis (MePGN) was the most common histological pattern, followed by focal and segmental glomerulosclerosis and other lesions. The common codeposits along with C1q were IgM, followed by C3 and others. MePGN had better prognosis than others. To conclude, C1qN was noted in 0.61% of all renal biopsies with bimodal age distribution and may present as podocytopathy or non-podocytopathy. The prognosis depends on the morphological pattern and C1q deposits per se are not prognostic indicators.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2015;volume=26;issue=2;spage=398;epage=403;aulast=Kanodia
spellingShingle K V Kanodia
A V Vanikar
R D Patel
K S Suthar
H V Patel
M A Gumber
P R Shah
H L Trivedi
C1q nephropathy in India: A single-center study
Saudi Journal of Kidney Diseases and Transplantation
title C1q nephropathy in India: A single-center study
title_full C1q nephropathy in India: A single-center study
title_fullStr C1q nephropathy in India: A single-center study
title_full_unstemmed C1q nephropathy in India: A single-center study
title_short C1q nephropathy in India: A single-center study
title_sort c1q nephropathy in india a single center study
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2015;volume=26;issue=2;spage=398;epage=403;aulast=Kanodia
work_keys_str_mv AT kvkanodia c1qnephropathyinindiaasinglecenterstudy
AT avvanikar c1qnephropathyinindiaasinglecenterstudy
AT rdpatel c1qnephropathyinindiaasinglecenterstudy
AT kssuthar c1qnephropathyinindiaasinglecenterstudy
AT hvpatel c1qnephropathyinindiaasinglecenterstudy
AT magumber c1qnephropathyinindiaasinglecenterstudy
AT prshah c1qnephropathyinindiaasinglecenterstudy
AT hltrivedi c1qnephropathyinindiaasinglecenterstudy